| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SHPRH_0001100 | Intergenic-Exon | chr6:146185524-146242528 | chr6:145864388-145921392 | 250 nt | 0.3800 |
| hsa_SHPRH_0001200 | Intergenic-Exon | chr6:146185524-146276490 | chr6:145864388-145955354 | 250 nt | 0.3760 |
| hsa_SHPRH_0001900 | Exon-Intergenic | chr6:146185531-146216108 | chr6:145864395-145894972 | 185 nt | 0.4541 |
| hsa_SHPRH_0002000 | Exon-Intergenic | chr6:146185531-146216113 | chr6:145864395-145894977 | 99 nt | 0.4646 |
| hsa_SHPRH_0002100 | Intergenic-Exon | chr6:146198083-146216113 | chr6:145876947-145894977 | 93 nt | 0.4731 |
| hsa_SHPRH_0002500 | Intergenic-Exon | chr6:146201656-146215372 | chr6:145880520-145894236 | 87 nt | 0.3333 |
| hsa_SHPRH_0002200 | Intergenic-Exon | chr6:146201656-146216108 | chr6:145880520-145894972 | 250 nt | 0.3960 |
| hsa_SHPRH_0002600 | Intergenic-Exon | chr6:146201656-146216113 | chr6:145880520-145894977 | 99 nt | 0.4848 |
| hsa_SHPRH_0002300 | Intergenic-Exon | chr6:146201656-146276490 | chr6:145880520-145955354 | 250 nt | 0.4120 |
| hsa_SHPRH_0002700 | Intergenic-Exon | chr6:146202451-146216113 | chr6:145881315-145894977 | 250 nt | 0.4000 |
A review of literature indicates that the circSHPRH is a tumor suppressor in brain cancer, specifically glioblastoma, where it is downregulated and its encoded SHPRH-146aa peptide inhibits glioma growth [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review of human studies indicates that the circSHPRH is downregulated in colorectal cancer tissues and is associated with metastasis and survival, while its overexpression inhibits proliferation and cell cycle progression [Lee et al. DOI:10.1016/j.biopha.2018.12.052].